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ABSTRACT
The purpose of this study was to examine sex differences in immune variables and
upper respiratory tract infection (URTI) incidence in 18-35 year-old athletes
engaged in endurance-based physical activity during the winter months. Eighty
physically active individuals (46 males, 34 females) provided resting venous
blood samples for determination of differential leukocyte counts, lymphocyte sub-
sets and whole blood culture multi-antigen stimulated cytokine production. Timed
collections of unstimulated saliva were also made for determination of saliva flow
rate, immunoglobulin A (IgA) concentration and IgA secretion rate. Weekly trai-
ning and illness logs were kept for the following 4 months. Training loads aver-
aged 10 h/week of moderate-vigorous physical activity and were not different for
males and females. Saliva flow rates, IgA concentration and IgA secretion rates
were significantly higher in males than females (all P < 0.01). Plasma IgA, IgG
and IgM concentrations and total blood leukocyte, neutrophil, monocyte and lym-
phocyte counts were not different between the sexes but males had higher num-
bers of B cells (P < 0.05) and NK cells (P < 0.001). The production of inter-
leukins 1β, 2, 4, 6, 8 and 10, interferon-γ and tumour necrosis factor-α in respon-
se to multi-antigen challenge were not significantly different in males and females
(all P > 0.05). The average number of weeks with URTI symptoms was 1.7 ± 2.1
(mean ± SD) in males and 2.3 ± 2.5 in females (P = 0.311). It is concluded that
most aspects of immunity are similar in men and women in an athletic population
and that the observed differences in a few immune variables are not sufficient to
substantially affect URTI incidence. Sex differences in immune function among
athletes probably do not need to be considered in future mixed gender studies on
exercise, infection and immune function unless the focus is on mucosal immunity
or NK cells.
Keywords: exercise training, leukocytes, immunoglobulins, cytokines, illness
122 • Sex differences in immunity and infection incidence in athletes
EIR 17 2011
Corresponding author:
Prof Michael Gleeson, School of Sport, Exercise and Health Sciences, Loughborough Uni-
versity, Loughborough, Leicestershire LE11 3TU, United Kingdom
Tel. 00 44(0)1509226345, Fax. 00 44(0)1509226301, E-mail: M.Gleeson@lboro.ac.uk
INTRODUCTION
Resistance to infection is strongly influenced by the effectiveness of the immune
system in protecting the host against pathogenic micro-organisms. Within the
general healthy human population there is a range of immuno-competency due to
genetic differences, age and lifestyle habits. The sex of the individual also affects
immune function. In females, oestrogens and progesterone modulate immune
function (32) and thus immunity is influenced by the menstrual cycle and preg-
nancy (21). Consequently, sex-based differences in responses to infection, trauma
and sepsis are evident (4). Women are generally more resistant to viral infections
and tend to have more autoimmune diseases than men (4). Oestrogens are gener-
ally immune enhancing, whereas androgens, including testosterone, exert sup-
pressive effects on both humoral and cellular immune responses. Females have
higher levels of plasma immunoglobulin (Ig) than men and exhibit more vigorous
responses to exogenous antigens, indicating a higher level of humoral immunity
in females than in males (6). In females, there is increased expression of some
cytokines in peripheral blood and vaginal fluids during the follicular phase of the
menstrual cycle and with use of hormonal contraceptives (7). In the luteal phase
of the menstrual cycle, blood leukocyte counts are higher than in the follicular
phase (12), mononuclear cell expression of the heterodimeric transcription factor
1 (a key regulator of the innate immune response) is lower (35), and the immune
response is shifted towards a T helper (Th) 2-type response (12). The expression
of pro-inflammatory and anti-inflammatory genes in response to exercise is also
influenced by the menstrual cycle and there are distinct differences in gene
expression between women in the luteal phase and men (29). Thus, in the general
population, there are differences in some aspects of immune function between
men and women that appear to result in women getting fewer viral infections
Prolonged strenuous exercise has been associated with a transient depression of
immune function (16, 17) and a heavy schedule of training and competition can
lead to immune impairment in athletes. This is associated with an increased sus-
ceptibility to infections, particularly upper respiratory tract infections (URTI) (5,
13, 18, 28, 34). However, it is not clear whether any substantial sex differences
exist in any aspect of immune function in an athletic population or whether any
such differences affect URTI risk.
The aims of the present study were to determine if sex differences exist in resting
immune variables including saliva immunoglobulin A (secretory IgA (SIgA))
secretion, plasma immunoglobulin concentrations, numbers of circulating leuko-
cyte and lymphocyte subsets and cytokine production by antigen-stimulated
whole blood culture in an athletic population. We also wished to determine if the
incidence of URTI was different in male and female athletes during a period of
winter training and competition. Our study population was a group of university
athletes on a single campus site so that environment and pathogen exposure were
likely to be similar for all subjects.
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METHODS
Subjects
One hundred and eight healthy university students who were engaged in regular
sports training (predominantly endurance-based activities such as running,
cycling, swimming, triathlon, team games and racquet sports) volunteered to par-
ticipate in the study. Subjects ranged from recreationally active to Olympic triath-
letes and their average self-reported training loads ranged averaged 9 h/week.
Subjects were required to complete a comprehensive health-screening question-
naire prior to starting the study and had not taken any medication in the 4 weeks
prior to the study. All subjects were fully informed about the rationale for the
study and of all experimental procedures to be undertaken. Subjects provided
written consent to participate in the study, which had earlier received the approval
of Loughborough University ethical advisory committee. Subjects were enrolled
after having fulfilled all inclusion criteria, and presenting none of the exclusion
criteria (determined by both questionnaire and interview).
Subjects could be included if they were currently healthy, had been involved in
endurance training for at least 2 years, engaged in at least 3 sessions and at least 3
h of total moderate/high intensity training time per week and were between 18-35
years of age. Subjects representing one or more of the following criteria were
excluded from participation: Smoking or use of any medication, abnormal haema-
tology (e.g. erythrocyte or leukocyte counts outside the normal range), suffered
from or had a history of cardiac, hepatic, renal, pulmonary, neurological, gastroin-
testinal, haematological or psychiatric illness.
Sample size estimation (14) of 41 subjects per gender group was based on an
expected rate of 2.0 ± 1.0 URTI episodes (mean ± SD) during the winter months
(27), a target difference of 30% in number of episodes (effect size 0.6), statistical
power of 80% and a type I error of 5%. We initially recruited 108 volunteers to
account for an estimated 25% drop-out rate over the study period. Of these 108
subjects, 50 were female and 58 were male and 80 subjects (34 females, 46
males) completed the study. Their baseline characteristics as shown in Table 1.
Self-reported weekly training loads (mean ± SD) were similar in males and
females (9.7 ± 4.7 and 8.7 ± 3.8 h/week, respectively, P = 0.339). Reasons for
dropout were given as foreign travel, injury or persistent illness (preventing sub-
jects from performing training) or due to undisclosed reasons.
Laboratory visit
The study began in November 2008. Subjects arrived at the laboratory in the
morning at 08.30-10:30 following an overnight fast of approximately 12 h. Each
subject was asked to empty their bladder before body mass and height were
recorded. Information about the study was given to them and they then signed an
informed consent form. Subjects then sat quietly for 10 min and completed a
health screen questionnaire, training habits questionnaire and inclusion/exclusion
criteria questionnaire before providing a saliva sample. With an initial swallow to
empty the mouth, unstimulated whole saliva was collected by expectoration into a
pre-weighed vial (7 ml-capacity plastic Bijou tubes with screw top) for 2 min
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with eyes open, head tilted slightly forward and making minimal orofacial move-
ment. Saliva flow rate (ml/min) was determined by weighing with saliva density
assumed to be 1.0 g/ml (9). All saliva samples were stored at –20°C until analysis.
Subsequently, a venous blood sample (11 ml) was obtained by venepuncture from
an antecubital vein and blood was collected into two Vacutainer tubes (Becton
Dickinson, Oxford, UK) containing either K3EDTA or heparin. Haematological
analysis was immediately carried out on the EDTA sample as detailed below.
Questionnaires
During the 4-month subsequent study period subjects were requested to continue
with their normal training programs and they completed a health (URTI symp-
toms) questionnaire on a weekly basis. Supplements (vitamins and minerals, etc.)
were not permitted during this period. Subjects were not required to abstain from
medication when they were suffering from illness symptoms but they were
required, on a weekly basis, to report any unprescribed medications taken, visits
to the doctor and any prescribed medications.
The illness symptoms listed on the questionnaire were: sore throat, catarrh in the
throat, runny nose, cough, repetitive sneezing, fever, persistent muscle soreness,
joint aches and pains, weakness, headache and loss of sleep. The non-numerical
ratings of light, moderate or severe (L, M or S, respectively) of severity of symp-
toms were scored as 1, 2 or 3, respectively to provide a quantitative means of data
analysis (15) and the total symptom score for every subject each week was calcu-
lated by multiplying the total number of days each symptom was experienced by
the numerical ratings of L, M or S symptoms of 1, 2 or 3, respectively. In any
given week a total symptom score ≥12 was taken to indicate that a URTI was
present. This score was chosen as to achieve it a subject would have to record at
least 3 moderate symptoms lasting for 2 days or 2 moderate symptoms lasting for
at least 3 days in a given week. A single URTI episode was defined as a period
during which the weekly total symptom score was ≥12 and separated by at least
one week from another week with a total symptom score ≥12. Subjects were also
asked to rate the impact of illness symptoms on their ability to train (normal train-
ing maintained, training reduced or training discontinued; L, M or S, respective-
ly). Subjects were also asked to fill in a standard short form International Physical
Activity Questionnaire (IPAQ; http://www.ipaq.ki.se/downloads.htm) at weekly
intervals, thus providing quantitative information on training loads in metabolic
equivalent (MET)-h/week (11).
Blood cell counts
Blood samples in the K3EDTA vacutainer (4 ml) were used for haematological
analysis (including haemoglobin, haematocrit and total and differential leukocyte
counts) using an automated cell-counter (Ac.TTM5diff haematology analyser,
Beckman Coulter, High Wycombe, UK). The intra-assay coefficient of variation
for all measured variables was less than 3.0%.
Lymphocyte subsets
Lymphocyte subsets (CD3, CD4, CD8, CD19, CD56) to enumerate total T cells,
T-helper cells, T-cytotoxic cells, B cells and NK cells, respectively were deter-
Sex differences in immunity and infection incidence in athletes • 125
EIR 17 2011
mined in whole blood samples by three-colour flow cytometry (Becton Dickinson
FACS-Calibur) with CellQuest analysis software (Becton Dickinson Biosciences,
Oxford, UK) as described previously (25). Forward scatter versus side scatter
plots were used to gate on the lymphocyte population by morphology and 10,000
lymphocyte events were acquired per analysis. Estimations of the absolute CD3+,
CD3+CD4+, CD3+CD8+, NK cell (CD3-CD56+) and B cell (CD3-CD19+) num-
bers were derived from the total lymphocyte count.
Monocyte TLR4 expression
The cell surface expression of toll-like receptor 4 (TLR4) in heparinised whole
blood was quantified (geometric mean fluorescence intensity) by flow cytometry
as described by Oliveira and Gleeson (31).
Antigen-stimulated cytokine production
Stimulated whole blood culture production of cytokines (IFN-γ, tumour necrosis
factor (TNF)-α, interleukin (IL)-1β, IL-2, IL-4, IL-6, IL-8 and IL-10) was deter-
mined as follows: 2 ml of heparinised whole blood was added to 2 ml of RPMI
medium (Sigma Chemicals, Poole, UK) with added stimulant at a dilution of
1:4000. The stimulant was a commercially available multi-antigen vaccine (Pedi-
acel Vaccine, Sanofi Pasteur, UK) containing diphtheria, tetanus, acellular pertus-
sis, poliomyelitis and haemophilus influenzae type b antigens. Whole blood was
cultured at 37°C and 5% CO2 for 24 h. After centrifugation at 1500 g for 10 min
at 4ºC, supernatants were collected and stored frozen at -80°C prior to analysis of
cytokine concentrations using an Evidence Investigator System using the cytokine
biochip array EV3513 (Randox, County Antrim, UK). The stimulant dilution of
1:4000 used in this study was based on a previous pilot experiment which estab-
lished the dose response curve for the measured cytokines over the dilution range
of 1:200 – 1:20000. The 1:4000 dilution increased production of all cytokines by
at least 4-fold above that of unstimulated whole blood culture, but induced less
than 50% of the cytokine production elicited by the highest dose.
Plasma immunoglobulins
The remaining blood in the K3EDTA tube was centrifuged at 1500 g for 10 min at
4 ºC within 10 min of sampling. The plasma obtained was immediately stored at
–80 ºC prior to analysis of immunoglobulins A, G and M (immunoturbidometric
assay on Pentra 400 autoanalyser, Horiba, France using the manufacturer’s cali-
brators and controls). The intra-assay coefficient of variation for immunoglobu-
lins A, G and M was 3.2%, 1.9% and 2.3%, respectively.
Saliva IgA
Duplicate saliva samples were analysed for SIgA using an ELISA kit (Salimet-
rics, Philadelphia, USA). The intra-assay coefficient of variation for SIgA was
3.6%. The SIgA secretion rate was calculated by multiplying the SIgA concentra-
tion by the saliva flow rate.
Statistical Analysis
Self-reported training load (h/week), average IPAQ scores (MET-h/week), anthro-
pometric and haematological variables were compared between males and
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females using unpaired t tests for normally distributed data. The blood leukocyte,
neutrophil, monocyte, eosinphil and lymphocyte counts, lymphocyte subset
counts, concentrations of secreted cytokines, sIgA concentrations and secretion
rates were compared between males and females using unpaired t tests for nor-
mally distributed data or nonparametric Mann-Whitney tests for data that were
not normally distributed. Statistical significance was accepted at P < 0.05. Data
are expressed as mean ± SD.
RESULTS
Anthropometric and haematological variables
There was no significant difference in age between males and females (Table 1)
but males were taller, heavier and had higher BMI than females (all P < 0.01).
Males had higher RBC count, haematocrit and haemoglobin concentration than
females (all P < 0.001).
Training loads
Analysis of the IPAQ questionnaires indicated that the weekly training loads were
relatively stable between and within the gender groups over the 4 months of the
study (Figure 1) and were equivalent to an average of about 11 h of moderate-vig-
orous activity per week. The self-reported training loads at the start of the study
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FIGURE 1 – Training loads in MET-h/week over the 4-month study period for men (n=46)
and women (n=34) who completed the study. Data are mean ± SD.
and the average IPAQ scores in MET-h/week over the 16 weeks of the study were
not significantly different between males and females (Table 1).
Plasma immunoglobulins and salivary variables
There were no differences between the sexes for plasma concentrations of IgA,
IgG and IgM (Table 2). Saliva flow rates, SIgA concentration and SIgA secretion
rates (Table 2) were significantly higher in males than females (all P < 0.01). For
male and female subjects combined, neither the concentration of SIgA nor its
secretion rate were related to the plasma IgA concentration (r = -0.122 and r =
0.059, respectively; both P > 0.05).
128 • Sex differences in immunity and infection incidence in athletes
EIR 17 2011
________________________________________________________________________________________________________ 
 
Males (n=46)  Females (n=34)  P 
________________________________________________________________________________________________________ 
 
Age (years) 22.9 ± 4.1   22.1 ± 4.0    0.425 
Height (cm)    1.81 ± 0.06  1.68 ± 0.06   <0.001 
Body mass (kg)   78.0 ± 10.5  62.6 ± 5.8   <0.001 
BMI (kg/m
2
) 23.8 ± 2.6  22.3 ± 2.3   0.005 
Training load (h/week)  9.7 ± 4.7  8.7 ± 3.8   0.339 
IPAQ (MET-h/week)  68.2 ± 39.0  63.4 ± 26.3   0.542 
RBC count (x10
12
/L)   5.01 ± 0.42  4.38 ± 0.38   <0.001 
Haematocrit (%)   43.1 ± 2.8  38.7 ± 2.6   <0.001 
Haemoglobin (g/L)   146 ± 9  130 ± 10   <0.001 
________________________________________________________________________________________________________ 
Values are expressed as mean (±SD). 
 
Table 1. – Anthropometric, training and haematological variables in male and female ath-
letes
________________________________________________________________________________________________________ 
 
Males (n=46)  Females (n=34)  P 
________________________________________________________________________________________________________ 
 
Plasma IgA (g/L)   1.52 ± 0.52  1.60 ± 0.50   0.842 
Plasma IgG (g/L)   10.16 ± 3.11  10.73 ± 1.71   0.246 
Plasma IgM (g/L)   1.40 ± 0.70  1.41 ± 0.70   0.888 
 
Total Ig (g/L)    12.99 ± 3.99  13.74 ± 2.29   0.360 
Saliva flow rate (ml/min)  0.50 ± 0.23  0.36 ± 0.20   0.008 
180 ± 116  123 ± 53   0.009 
µg/min) * 81.4 ± 55.5  43.8 ± 29.4   <0.001 
________________________________________________________________________________________________________ 
Values are expressed as mean (±SD). Asterisks indicate data sets that were not normally distributed. 
SIgA concentration (mg/L)*  
SIgA secretion rate (
Table 2. Plasma immunoglobulins and salivary variables in male and female athletes
Blood leukocytes, lymphocyte subsets and monocyte TLR4 expression
Total blood leukocyte, neutrophil, monocyte and lymphocyte counts were not sig-
nificantly different (Table 3) but males had higher numbers of B cells (P < 0.05)
and NK cells (P < 0.001) as illustrated in Table 4. Monocyte TLR4 expression
tended to be lower in males (geometric mean fluorescence intensity: 26.1 ± 13.6
in females, 20.5 ± 12.3 in males, P = 0.062).
Antigen stimulated cytokine production
The production of interleukins 1β, 2, 4, 6, 8 and 10, IFN-γ and TNF-α by multi-
antigen stimulated whole blood culture were not significantly different in males
and females (Table 5).
URTI incidence and severity and duration of URTI symptoms
The average number of weeks with URTI symptoms was 1.7 ± 2.1 in males and
2.3 ± 2.5 in females (P = 0.311). For weeks when an URTI episode was present
(i.e. total symptom severity score of 12 or more), the mean total symptom severi-
ty score was 22 ± 7 and 22 ± 11 in males and females, respectively and the mean
duration of symptoms was 3.6 ± 1.5 and 3.4 ± 1.5 days in males and females,
respectively.
Sex differences in immunity and infection incidence in athletes • 129
EIR 17 2011
________________________________________________________________________________________________________ 
 
Males (n=46)  Females (n=34)  P 
________________________________________________________________________________________________________ 
 
Leukocyte count (x10
9
/L)  5.66 ± 1.32  5.89 ± 1.60   0.477 
Neutrophil count (x10
9
/L)  2.71 ± 1.05  3.20 ± 1.25   0.062 
Monocyte count (x10
9
/L)  0.51 ± 0.17  0.47 ± 0.14   0.212 
Eosinophil count (x10
9
/L)  0.19 ± 0.12  0.18 ± 0.13   0.753 
Lymphocyte count (x10
9
/L)  2.17 ± 0.53  1.97 ± 0.60   0.127 
________________________________________________________________________________________________________ 
Values are expressed as mean (±SD). 
 
Table 3. Blood leukocyte counts in male and female athletes
________________________________________________________________________________________________________ 
 
Males (n=46)  Females (n=34)  P 
________________________________________________________________________________________________________ 
 
CD3+ cell count (x10
9
/L)  1.28 ± 0.45  1.24 ± 0.43   0.718 
CD3+CD4+ cell count (x10
9
/L) 0.68 ± 0.25  0.70 ± 0.23   0.729 
CD3+CD8+ cell count (x10
9
/L) 0.53 ± 0.28  0.48 ± 0.20   0.335 
CD3-CD19+ cell count (x10
9
/L) 0.23 ± 0.13  0.18 ± 0.09   0.048 
CD3-CD56+ cell count (x10
9
/L) 0.30 ± 0.17  0.16 ± 0.07   <0.001 
________________________________________________________________________________________________________ 
Values are expressed as mean (±SD). 
 
Table 4. Blood lymphocyte subset counts in male and female athletes
DISCUSSION
The main findings of the present study were that most aspects of immunity are not
different between males and female athletes but a few that could potentially influ-
ence URTI risk – SIgA concentration and secretion rate, numbers of circulating B
cells and NK cells – are lower in women than in men in an athletic population.
However, these differences are not sufficient to substantially affect URTI inci-
dence. In contrast monocyte TLR4 expression tended to be higher in females
which may compensate for other aspects of their immune function being lower
(19). Sex differences in immune function among athletes therefore probably do
not need to be considered in future mixed gender studies on exercise, infection
and immune function, unless the focus of the study is on mucosal immunity or
NK cells.
Low SIgA concentration or secretion rate has been identified as a risk factor for
development of URTI in physically active individuals (13, 18, 20, 27). It has been
suggested that SIgA levels are a surrogate marker of host protection and the sup-
pression of SIgA after prolonged exercise or heavy training is itself a probable
consequence of altered T lymphocyte function (10). Females generally have
lower unstimulated saliva flow rates than males (33), whereas SIgA concentration
in unstimulated saliva has been reported to be unaffected by sex among relatively
large cohorts of healthy young adults (24, 36, 37). A previous small scale study
reported lower SIgA concentration and secretion rate in females (n=8) than in
males (n=8) among subjects of mixed fitness (3). Two small scale studies on elite
swimmers have also reported lower SIgA concentrations in females compared
with males (n= 11 females, n = 15 males (18); n = 5 females, n= 7 males (2)); but,
to our knowledge, our investigation is the first large scale study to report a sex dif-
ference in SIgA secretion in athletes from a range of endurance-based sports.
Despite the markedly lower SIgA concentration and secretion rate in females, the
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________________________________________________________________________________________________________ 
 
Males (n=46)  Females (n=34)  P 
________________________________________________________________________________________________________ 
 
IL-1β production (pg/ml)*  9.1 ± 9.9  5.9 ± 4.8   0.114 
IL-2 production (pg/ml)*  140 ± 227  118 ± 138   0.996 
IL-4 production (pg/ml)*  3.4 ± 4.1  4.6 ± 7.6   0.981 
IL-6 production (pg/ml)*  167 ± 133  135 ± 124   0.375 
IL-8 production (pg/ml)*  1178 ± 738  897 ± 653   0.133 
IL-10 production (pg/ml)*  4.0 ± 5.3  3.8 ± 4.6   0.680 
IFN-γ production (pg/ml)*  31 ± 59  26 ± 53   0.431 
TNF-α production (pg/ml)*  27 ± 46  17 ± 25   0.166 
________________________________________________________________________________________________________ 
Values are expressed as mean (±SD). Asterisks indicate data sets that were not normally distributed. 
Table 5. Antigen stimulated cytokine production by whole blood culture in male and female
athletes.
incidence of URTI was not significantly influenced by sex so the clinical signifi-
cance of the sex difference in SIgA secretion is unclear.
In the general population, women have been reported to have fewer blood mono-
cytes and NK cells, more CD4+ cells and more neutrophils than men (6, 38) and
women appear to suffer from fewer viral infections than men (4). Most URTI are
of viral origin but in the present study URTI incidence was not significantly dif-
ferent between the sexes. It is possible that the same training load could have a
greater depressive effect on humoral immunity (lower SIgA and numbers of cir-
culating B cells) for women than for men (that is not evident in the normal, more
sedentary population) but this possibility needs to be resolved by future research.
Such an effect may be responsible for the reversal of the usual situation of higher
immune function in females into the opposite situation in our athlete cohort. A
limitation of the present study is that the phase of the menstrual cycle (when
blood and saliva samples were taken) was not determined and we did not establish
whether the females were taking oral contraceptives. It is possible that the high
training loads of some of the female endurance athletes in our study could have
caused them to be amenorrhoic and one would expect that this would make their
immune variables more similar to that of men. This aside, menstrual cycle phase
was not found to affect resting SIgA responses in endurance trained female ath-
letes (8).
In healthy normal adults, small differences in single selected markers of immune
function may not be clinically important. There are two main reasons for this.
Firstly, there is a considerable degree of redundancy in the immune system, such
that a small change in the functional capacity of one component of immune func-
tion may be compensated for by a change in the functional capacity of another.
Secondly, there may be a certain amount of excess capacity in some aspects of
immune function, particularly for those functions that are assessed using in vitro
challenges using a high concentration of stimulant (1). Thus, it cannot be stated
with any degree of certainty that small differences in one or more aspects of
immune function will influence an individual’s susceptibility to infection. Indeed
for many aspects of immune function (e.g. blood neutrophil count and oxidative
burst activity), it is not even known if the normal variation seen in the healthy
adult population is a factor that influences the ability to fight infections (23).
More substantial differences in one or more aspects of immune function are prob-
ably more likely to affect infection risk although this also depends on the degree
of exposure to pathogens and the experience of previous exposure. However, for
some immune cell functions a sufficiently large variation or change has been
related to altered host defence and susceptibility to disease. For example, some
studies indicate that susceptibility to infections and cancer is greater in individu-
als who possess low NK cell activity compared with individuals with moderate to
high NK cell activity (22, 26, 30).
Associations between URTI risk and blood immune parameters have not been
extensively examined, though an impaired IFN-γ production in unstimulated
whole blood culture has been reported in fatigued and illness-prone endurance
athletes (10). However, the relevance of this measure of immune function to
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infection risk is unclear as cytokine production in the unstimulated state is very
low compared with the response to an infectious agent or antigen challenge.
Immune functions in females are influenced by endogenous oestrogenic effects
(6, 32). In addition, endogenous hormones during the menstrual cycle in female
subjects and exogenous hormones in the form of contraceptives or of hormone
replacement therapy, affect immune functions such as cytokine production (21),
which requires female subjects to be classified as premenopausal (with and with-
out contraceptives) or postmenopausal (with or without hormone replacement
therapy). However, Burrows et al. (8) found no differences in SIgA concentration
or secretion rate in a group of highly trained female endurance runners over the
phases of the menstrual cycle and there was no relationship between SIgA and
progesterone concentrations. In the present study the whole blood culture produc-
tion of measured cytokines in response to multi-antigen challenge was not differ-
ent in females compared with males. Blood leukocyte, neutrophil, monocyte and
lymphocyte counts were also similar in athletic men and women. Circulating
numbers of T cells and CD4+ and CD8+ subsets similar as well so it is important
to emphasise that most aspects of immunity measured in our study were not dif-
ferent between the sexes. The lower number of circulating B cells and NK cells in
females in the present study cannot necessarily be interpreted as meaning lower
immune function because it may be that activated cells have moved out of the cir-
culation into the skin, lung, gut, lymph nodes etc. Thus, sex differences in
immune function among athletes probably do not need to be considered in future
mixed gender studies on exercise, infection and immune function, unless the
focus of the study is mucosal immunity or NK cells.
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